Center for Scientific Review and National Institute of Allergy and Infectious Diseases; Amended Notice of Closed Meeting, 84163-84164 [2024-24240]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices
CFR 60.30), any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period. To
meet its burden, the petition must
comply with all the requirements of
§ 60.30, including but not limited to:
must be timely (see DATES), must be
filed in accordance with § 10.20, must
contain sufficient facts to merit an FDA
investigation, and must certify that a
true and complete copy of the petition
has been served upon the patent
applicant. (See H. Rept. 857, part 1, 98th
Cong., 2d sess., pp. 41–42, 1984.)
Petitions should be in the format
specified in 21 CFR 10.30.
Submit petitions electronically to
https://www.regulations.gov at Docket
No. FDA–2013–S–0610. Submit written
petitions (two copies are required) to the
Dockets Management Staff (HFA–305),
Food and Drug Administration, 5630
Fishers Lane, Rm. 1061, Rockville, MD
20852.
Dated: October 10, 2024.
Eric Flamm,
Acting Associate Commissioner for Policy.
[FR Doc. 2024–24187 Filed 10–18–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular and Hematological
Studies.
Date: November 13, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
VerDate Sep<11>2014
16:27 Oct 18, 2024
Jkt 265001
Contact Person: Dmitri V. Gnatenko, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, gnatenkod2@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Musculoskeletal, Skin and Oral
Sciences.
Date: November 14, 2024.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Health Services and Systems.
Date: November 14–15, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Michael J. McQuestion,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
Bethesda, MD 20892, 301–480–1276,
mike.mcquestion@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Neuro
Informatics, Computational and Data
Analysis.
Date: November 14, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Joseph G. Rudolph, Ph.D.,
Chief and Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, 301–408–
9098, josephru@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neurodegenerative and Neurological
Disorders.
Date: November 14–15, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kathryn Partlow, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
84163
Bethesda, MD 20892, (301) 594–2138,
partlowkc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Clinical Care and Health
Interventions.
Date: November 14–15, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: In-Person and Virtual
Meeting.
Contact Person: Trina Colleen Salm Ward,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–5254, salmwardtc@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Brain Disorders and Related
Neurosciences.
Date: November 14–15, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Vilen A Movsesyan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24236 Filed 10–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review and
National Institute of Allergy and
Infectious Diseases; Amended Notice
of Closed Meeting
Notice is hereby given of changes
pertaining to the meeting of the Center
for Scientific Review Special Emphasis
Panel, Fellowship: NIH Medical
Scientist Partnership Program (FM1),
October 31, 2024, 9:00 a.m. to November
1, 2024, 06:00 p.m., National Institutes
of Health, Rockledge II, 6701 Rockledge
Drive, Bethesda, MD 20892, which was
published in the Federal Register on
E:\FR\FM\21OCN1.SGM
21OCN1
84164
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices
October 9, 2024, 89 FR 81923, Doc
2024–23354.
The notice of the meeting is being
amended to change the name of the
committee from Center for Scientific
Review Special Emphasis Panel;
Fellowship: NIH Medical Scientist
Partnership Program (FM1) to National
Institute of Allergy and Infectious
Diseases Special Emphasis Panel;
Fellowship: NIH Medical Scientist
Partnership Program (FM1). The notice
is also being amended to change the
address of the meeting from National
Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 to
National Institute of Allergy and
Infectious Diseases, National Institutes
of Health, 5601 Fishers Lane, Room
3G45, Rockville, MD 20892. The contact
information for the meeting has also
been updated from Raj K. Krishnaraju,
Ph.D. to Frank S. De Silva, Ph.D.,
Scientific Review Officer, National
Institute of Allergy and Infectious
Diseases, National Institutes of Health,
5601 Fishers Lane, MSC 9823,
Rockville, MD 20892, (240) 669–5023,
fdesilva@niaid.nih.gov. The date and
time of the meeting remain the same.
The meeting is closed to the public.
Dated: October 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24240 Filed 10–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
VerDate Sep<11>2014
16:27 Oct 18, 2024
Jkt 265001
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: November 14, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G31B, Rockville, MD
20892, (240) 669–5060, james.snyder@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24242 Filed 10–18–24; 8:45 am]
National Institutes of Health, Rockledge II,
Room 903–F, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 435–0229,
ryank2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 15, 2024.
Miguelina Perez,
Program Analyst Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24241 Filed 10–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel (ZOD1), Office of Research
Infrastructure Programs (ORIP) Special
Emphasis Panel: Applications for Scientific
Conferences.
Date: November 26, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Center
for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Scientific
Review Officer, Center for Scientific Review,
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel:
International Bioethics Research Education,
Curriculum Development and Training.
Date: November 12, 2024.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Abigail A. Haydon, Ph.D.,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Dr.,
Bethesda, MD 20892, (301) 435–4806,
haydonaba@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Societal and
Ethical Issues in Research.
Date: November 12–13, 2024.
Time: 1:45 p.m. to 1:00 p.m.
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 89, Number 203 (Monday, October 21, 2024)]
[Notices]
[Pages 84163-84164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24240]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review and National Institute of Allergy
and Infectious Diseases; Amended Notice of Closed Meeting
Notice is hereby given of changes pertaining to the meeting of the
Center for Scientific Review Special Emphasis Panel, Fellowship: NIH
Medical Scientist Partnership Program (FM1), October 31, 2024, 9:00
a.m. to November 1, 2024, 06:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, which was
published in the Federal Register on
[[Page 84164]]
October 9, 2024, 89 FR 81923, Doc 2024-23354.
The notice of the meeting is being amended to change the name of
the committee from Center for Scientific Review Special Emphasis Panel;
Fellowship: NIH Medical Scientist Partnership Program (FM1) to National
Institute of Allergy and Infectious Diseases Special Emphasis Panel;
Fellowship: NIH Medical Scientist Partnership Program (FM1). The notice
is also being amended to change the address of the meeting from
National Institutes of Health, Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 to National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20892. The contact information for the meeting has also
been updated from Raj K. Krishnaraju, Ph.D. to Frank S. De Silva,
Ph.D., Scientific Review Officer, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers Lane,
MSC 9823, Rockville, MD 20892, (240) 669-5023, [email protected].
The date and time of the meeting remain the same. The meeting is closed
to the public.
Dated: October 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24240 Filed 10-18-24; 8:45 am]
BILLING CODE 4140-01-P
